Janet Cheetham

Amgen (United States)

Papers

1

Total Citations

52

H-Index

1

About

Dr. Janet Cheetham is a leading figure in pharmaceutical drug discovery, whose work has fundamentally advanced the crucial field of physicochemical property optimization. Her research centers on developing high-throughput methodologies to assess drug-like properties, with a particular focus on aqueous solubility—a key determinant of a compound's bioavailability and success in lead optimization. Her seminal 2005 paper, "An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead Optimization," which has garnered 52 citations, introduced a groundbreaking automated equilibrium solubility assay. This work was instrumental in enabling robust structure-property relationship (SPR) studies, allowing medicinal chemists to rapidly and reliably identify promising drug candidates by linking molecular structure to solubility. By providing a sensitive, high-throughput solution to a historically challenging bottleneck, Dr. Cheetham’s contributions have empowered researchers to make data-driven decisions earlier in the pipeline, significantly accelerating the journey from lead compound to therapeutic. Her legacy is that of a pioneer who transformed a critical analytical challenge into a streamlined, enabling tool for modern drug design.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead Optimization
52 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago